Clinical Trial Update: Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) [Phase 2]

View source ↗

Summary

Phase 2 feasibility and efficacy study of a conditioning regimen using fludarabine, busulfan, and total body irradiation before allogeneic hematopoietic cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Lymphoma
• Myelodysplastic Syndromes

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• Total Body Irradiation

Snippet

Sponsor: Samsung Medical Center | Conditions: AML, MDS | Phase 2 | Status: UNKNOWN